Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria

scientific article published on 01 February 2008

Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JN/138.2.316
P698PubMed publication ID18203898

P2093author name stringXiaowen Liu
Denise M Ney
Sandra C van Calcar
Mark R Etzel
Angela K Hull
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmurine modelQ122890741
P304page(s)316-322
P577publication date2008-02-01
P1433published inJournal of NutritionQ3186931
P1476titleDietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria
P478volume138

Reverse relations

cites work (P2860)
Q37550329Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice
Q49500552Dietary intervention in the management of phenylketonuria: current perspectives.
Q30415470Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice
Q42401605Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
Q35900593Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria
Q64247911Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
Q24645084Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids
Q54839680Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.
Q50571787New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation.
Q24613843Nutritional Management of Phenylketonuria
Q36786748Nutritional management of PKU with glycomacropeptide from cheese whey
Q50733179Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
Q45298394Phenylketonuria Scientific Review Conference: state of the science and future research needs
Q36092265Phenylketonuria: nutritional advances and challenges
Q39819235Protein substitutes for phenylketonuria in Europe: access and nutritional composition
Q36783467Purification and use of glycomacropeptide for nutritional management of phenylketonuria
Q39676007The Use of Glycomacropeptide in Dietary Management of Phenylketonuria.
Q59797027The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
Q41590941Voluntary Exercise Prevents Oxidative Stress in the Brain of Phenylketonuria Mice

Search more.